Showing results (211-220 of 277) with videos related to

Sort By:
Pageof 28
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2022
Report of the First International Symposium on NUT CarcinomaChristopher A French, Michael L Cheng, Glenn J Hanna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2026
Avutometinib, Abemaciclib, and Fulvestrant in Patients with HR+/HER2- Metastatic Breast Cancer Previously Treated with CDK4/6 Inhibitor: A Single-Arm Phase I TrialAdrienne G Waks, Elia Segui, Tianyu Li, et al.
JCO Precision Oncology|December 5, 2025
Presenting Features and Causes of Diagnostic Delays: A Report From the NUT Carcinoma RegistrySara A Walton, Justin J Kim, Francesco Paoloni, et al.
Gynecologic Oncology|May 17, 2024
A phase 2 trial exploring the significance of homologous recombination status in patients with platinum sensitive or platinum resistant relapsed ovarian cancer receiving combination cediranib and olaparibJoyce F Liu, Niya Xiong, Robert M Wenham, et al.
Cancer Cell|July 7, 2007
Bronchial and peripheral murine lung carcinomas induced by T790M-L858R mutant EGFR respond to HKI-272 and rapamycin combination therapyDanan Li, Takeshi Shimamura, Hongbin Ji, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2021
Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCTWilliam D Tap, Arun S Singh, Stephen Patrick Anthony, et al.
Cancer Discovery|September 15, 2018
Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer OrganoidsSarah J Hill, Brennan Decker, Emma A Roberts, et al.
British Journal of Cancer|December 10, 2021
Combined PARP and HSP90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumoursPanagiotis A Konstantinopoulos, Su-Chun Cheng, Jeffrey G Supko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2023
National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)Funda Meric-Bernstam, James M Ford, Peter J O'Dwyer, et al.
The New England Journal of Medicine|September 30, 2014
Crizotinib in ROS1-rearranged non-small-cell lung cancerAlice T Shaw, Sai-Hong I Ou, Yung-Jue Bang, et al.
Pageof 28